Home › Trial NCT06516679
Efficacy of Risk-Stratified Treatment in Newly Diagnosed Infant Leukemia
- Trial IDNCT06516679
- StatusRecruiting
- PhasePhase 2
- Study typeInterventional
- SponsorYonsei University
- Enrollment40
- Start date2024-12-11
- ConditionsLeukemia, Lymphoid
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.